Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New insulin pump system shows promise for type 2 diabetes control

NCT ID NCT07276776

First seen Jan 05, 2026 · Last updated May 24, 2026 · Updated 17 times

Summary

This study tested the Omnipod M System, a wearable insulin pump, in 40 adults aged 18-75 with type 2 diabetes. The goal was to see if the system helps keep blood sugar levels in a safe range and reduces dangerous highs and lows. Participants used the system for 6 weeks while researchers tracked glucose metrics.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Disease & Glandular Disease Clinic

    San Antonio, Texas, 78229, United States

  • Henry Ford Health

    Detroit, Michigan, 48202, United States

  • Joslin Diabetes

    Boston, Massachusetts, 02215, United States

  • MassResearch LLC.

    Waltham, Massachusetts, 02453, United States

  • Mountain Area Health Educational Center ( MAHEC)

    Asheville, North Carolina, 28803, United States

  • Texas Diabetes and Endocrinology (TDE)

    Austin, Texas, 78731, United States

Conditions

Explore the condition pages connected to this study.